BRIVARACETAM

Generic: BRIVARACETAM

ScieGen PharmaceuticalsManufacturer
ORALRoute
BRIVARACETAMActive Substance
2026-07-01Original Approval

BRIVARACETAM is FDA application ANDA219952, sponsored by SCIEGEN PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
SEIZURE
1,984 reports
2
DRUG INEFFECTIVE
656 reports
3
OFF LABEL USE
613 reports
4
THERAPY INTERRUPTED
339 reports
5
OVERDOSE
277 reports
6
FATIGUE
253 reports
7
SOMNOLENCE
252 reports
8
PRODUCT AVAILABILITY ISSUE
237 reports
9
FALL
231 reports
10
DIZZINESS
225 reports